SCHEMBL7863738

SCHEMBL7863738

CC(C)(C)c1ccc(C=NNc2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.68
GAA P10253 7/20 0.68
KMT2A Q03164 5/20 0.68
MEN1 O00255 4/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
HPGD P15428 3/20 0.68
MITF O75030 1/20 0.68
NOX1 Q9Y5S8 2/20 0.67
RAB9A P51151 6/20 0.66
NPC1 O15118 5/20 0.66
LMNA P02545 2/20 0.62
ESRRG P62508 1/20 0.59
MAOA P21397 2/20 0.52
MAOB P27338 2/20 0.52
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 1/20 0.50
ALOX12 P18054 1/20 0.50
TRPV1 Q8NER1 1/20 0.48
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863736 1.00 MAPT (0.68) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL11388174 0.85 NOX1 (0.91) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL11388177 0.85 NOX1 (0.91) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL31429973 0.83 MAPT (0.69) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL26915332 0.82 MAPT (1.00) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL26935010 0.82 MAPT (1.00) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL42160 0.81 NOX1 (1.00) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL22874080 0.81 NOX1 (1.00) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL42159 0.81 NOX1 (1.00) MAPTGAAKMT2AMEN1SMN1; SMN2
SCHEMBL11434619 0.80 NOX1 (0.74) MAPTGAAKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260009142-A1 Electrochemical synthesis of pyrazolines and pyrazoles BAYER AG (DE) 2026-01-08 US disclosed
CN-119698496-A Electrochemical synthesis of pyrazolines and pyrazoles 拜耳公司 2025-03-25 CN disclosed
EP-0729139-B1 Optical recording medium using formazan metal complex dye TDK CORP (JP) 2001-02-07 EP disclosed
US-5604004-A Optical recording medium using formazan metal complex dye and photo-stabilizing method TDK CORPORATION (JP) 1997-02-18 US disclosed
EP-0729139-A1 Optical recording medium using formazan metal complex dye and photo-stabilizing method TDK Corporation (JP) 1996-08-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260009142-A1 Electrochemical synthesis of pyrazolines and pyrazoles CYP2E1, CYP2F1, CYP4F2 MAPT 4836/4885GAA 3100/4885KMT2A 3774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.